The Role of Bub1 in SV40 Large T Mediated Transformation
The Role of Bub1 in SV40 Large T Mediated Transformation
批准号:
8233029
负责人:
THOMAS M ROBERTS
金额:
$39.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31
关键词:
AllelesAneuploidyAntigensCell AgingCellsChromosome abnormalityComplexDNA Tumor VirusesDataDominant-Negative MutationEventFamily memberGeneticGenome StabilityGenomic InstabilityGrantHumanLarge T AntigenLeadMalignant NeoplasmsMediatingMitoticMitotic spindleMonitorMutateMutationNormal CellOncogenesOncogenicPapovaviridaePhenotypePhosphorylationPhosphotransferasesPlayProtein p53ProteinsRNA InterferenceRoleSerineSimian virus 40Tumor Suppressor ProteinsViralViral Tumor AntigensViruscell transformationgenetic analysisinterestscaffoldsenescencesmall hairpin RNAtransforming virustumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have discovered an interesting set of functional interactions among three proteins: SV40 Large T
antigen (LT), the p53 tumor suppressor protein and the mitotic kinase Bub1. Bub1 is a member of the family
of checkpoint proteins that monitor the assembly of the mitotic spindle, and has been found to be mutated in
certain human cancers characterized by aneuploidy. LT antigen can also cause genomic instability by
inducing chromosomal aberrations and aneuploidy. Genetic analysis demonstrates that interaction of T
antigen with Bub1 is not required for immortalization but is necessary for T antigen to drive viral replication
and transform. Notably LT appears to act as a scaffold bringing Bub1 to p53, which then is phosphorylated
on ser37 directly by Bub1 and on ser15, indirectly by a second kinase, leading to the stabilization of p53.
Preliminary data suggests that this stabilization fo p53 is necessary for transformation by LT at least in
certain circumstances. Also of note is finding that downregulating Bub1 function either by LT expression or
by RNAi against Bub1 in the absence of LT, results in p53 dependent cellular senescence, accompanied by
phosphorylation of ser37. Recently another group has demonstrated that ras induced senescence, which
we can block with a dominant negative allele of Bub1, is also dependent on phosphorylation of p53 at serine
37. The key questions in the context of this grant are how Bub1 contributes to LT mediated replication and
transformation and to suppressing tumor formation via senescence in the absence of LT. We can imagine
several possible mechanisms: LT may use Bub1 to regulate replication and transformation via its direct
phosphorylation of p53, via Bub1 mediated phosphorylation of other targets in the LT complex or more
indirectly via by perverting Bubl's role in regulating genome stability. These mechanisms need not be
mutually exclusive. Obviously similar mechanisms may be in play as Bub1 guards "normal" cells from
transformation by promoting senescence. In this application we propose to probe each of these
mechanisms in turn.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:9816457
-
项目类别:
-
资助金额:$92.54万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10238853
-
项目类别:
-
资助金额:$104.98万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:9978752
-
项目类别:
-
资助金额:$104.98万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10705059
-
项目类别:
-
资助金额:$102.88万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
-
批准号:10468110
-
项目类别:
-
资助金额:$102.88万
-
财政年份:2019
-
负责人:THOMAS M ROBERTS
-
依托单位:
PROJECT 2: Oncogenic Transformation via the PP2A/YAP/Hippo pathway
-
批准号:10227783
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2017
-
负责人:THOMAS M ROBERTS
-
依托单位:
PROJECT 2: Oncogenic Transformation via the PP2A/YAP/Hippo pathway
-
批准号:9981671
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2017
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting the PI3K Signaling Axis
-
批准号:8588487
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2013
-
负责人:THOMAS M ROBERTS
-
依托单位:
Overcoming Resistance to Standard HER2-Directed Therapies for Breast Cancer
-
批准号:8607754
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2013
-
负责人:THOMAS M ROBERTS
-
依托单位:
Amoeboid Motility--A Cellular and Genetic Approach
-
批准号:7892239
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase
-
批准号:7852681
-
项目类别:
-
资助金额:$130.29万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
The Role of Bub1 in SV40 Large T Mediated Transformation
-
批准号:7647584
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase
-
批准号:7942793
-
项目类别:
-
资助金额:$135.08万
-
财政年份:2009
-
负责人:THOMAS M ROBERTS
-
依托单位:
Project 2 - Effects of Herb Fractions on Cell Function/Regulation:
-
批准号:7048909
-
项目类别:
-
资助金额:$5.54万
-
财政年份:2005
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7227166
-
项目类别:
-
资助金额:$68.63万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7413945
-
项目类别:
-
资助金额:$69.15万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:6826346
-
项目类别:
-
资助金额:$66.45万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:7076835
-
项目类别:
-
资助金额:$68.79万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
-
批准号:6922876
-
项目类别:
-
资助金额:$68.48万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
Determining the Role of Bub1 in T Antigen Mediated Transformation
-
批准号:6989674
-
项目类别:
-
资助金额:$26.57万
-
财政年份:2004
-
负责人:THOMAS M ROBERTS
-
依托单位:
海外基金